Adjunctive role of self-retained cryopreserved amniotic membrane in treating immune-related dry eye disease

• Published in: International ophthalmology 2018-10, Vol.38 (5), p.2219-2222
• Main Authors: Cheng, Anny M. S., Tighe, Sean, Sheha, Hosam, Tseng, Scheffer C. G.
• Format: Article
• Language: English
• Subjects: Arthritis; Case Report; Eye diseases; Filaments; Immunotherapy; Keratitis; Medicine; Medicine & Public Health; Membranes; Ophthalmology; Plugs; Steroids; Visual acuity
• ISSN: 0165-5701; 1573-2630
• DOI: 10.1007/s10792-017-0708-y

Purpose To present a case of successful treatment of immune-related severe dry eye disease (DED) by self-retained cryopreserved amniotic membrane (CAM) in conjunction with conventional and systemic immunotherapy. Observations A 48-year-old female with a 10-year history of rheumatoid arthritis under systemic immunomodulation developed non-resolved severe ocular dryness, pain, photophobia and blurred vision due to corneal epithelial keratopathy OD much worse than OS despite topical artificial tears, steroids, cyclosporine, autologous serum drops, punctal plugs and scleral lens for the last 3 years. During the first year, she received punctal cauterization and a total of 6 CAM, each for an average of 7.2 ± 2.3 days, for recurrent diffuse superficial punctate keratitis (SPK) with filaments to achieve an average symptom-free period of 2.4 ± 0.9 months and visual acuity improvement from 20/400 to 20/200. During the next 2 years, she received surgical closure of puncta for recurrent punctal reopening, additional systemic immunomodulation and a total of 4 CAM, each for an average of 8.5 ± 2 days, for recurrent scattered SPK, to achieve an average symptom-free period of 6.4 ± 1 months and visual acuity improvement from 20/200 to 20/70. Conclusions Self-retained CAM can be an adjunctive treatment for immune-related DED, which is refractory to conventional and systemic immunotherapies.